Black individuals have the shortest survival of any racial and ethnic group in the US for most cancers, including cutaneous melanoma.1 Complex factors, such as socioeconomic differences, lower health care access, structural racism, and higher rates of medical comorbidities, likely contribute to these inequalities. The observed differences in melanoma survival rates across racial groups have led to calls for intensifying primary (ie, ultraviolet radiation [UVR] protection) and secondary (ie, physician screening and/or self-examinations) prevention strategies for Black individuals.2,3 However, before doing so, it is crucial to carefully consider the risk factors, incidence, mortality, and survival rates of targeted populations, as well as the potential benefits and harms of any proposed interventions.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Marchetti MA, Adamson AS, Halpern AC. Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes. JAMA Dermatol. Published online July 21, 2021. doi:10.1001/jamadermatol.2021.2215
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: